EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline

@article{Fairchild1980EEGEO,
  title={EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline},
  author={M. David Fairchild and Donald J. Jenden and Max R. Mickey and Coralee Yale},
  journal={Pharmacology Biochemistry and Behavior},
  year={1980},
  volume={12},
  pages={99-105}
}

Serotonin and the psychedelics

Baseline studies and anticonvulsant drug effects on the sleep EEG power spectral profile.

Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids

Although psilocybin-containing mushrooms are not what Nordic mushroom pickers are trying to find as food or food supplement, there is a risk, admittedly small, that these mushrooms accidentally will be collected and this may be a legal problem in some Nordic countries.

Relationship between electrocortical activity and Β-adrenergic receptor function in the rat after chronic desimipramine treatment

Data indicate that chronic treatment with DMI, resulting in a down-regulation of the cortical Β-adrenergic system, is paralleled by pronounced effects on the ECoG of rats, and suggests that adaptive changes in the electrical brain activity continually develop during the chronic treatment of this antidepressant drug.

UNIVERSIDADE FEDERAL DE PERNAMBUCO CENTRO DE FILOSOFIA E CIÊNCIAS HUMANAS DEPARTAMENTO DE PSICOLOGIA DOUTORADO EM PSICOLOGIA COGNITIVA

ESCOBAR, J. A. C. Ayahuasca and Health: Effects of a Psychoactive Sacramental Drink in the Mental Health of Religious Ayahuasqueros. 260 f. Thesis (Doctoral) – Graduate Program on Cognitive

References

SHOWING 1-10 OF 23 REFERENCES

An animal behavior model for studying the actions of LSD and related hallucinogens.

Cats injected with LSD exhibit a group of behaviors that appear to be specific to hallucinogenic drugs, which represent an animal model that can be used in studies of the effects of LSD and related hallucinogens.

The pharmacology of hallucinogens.

In the context of the yawning abyss of ignorance and speculation which separates biochemical and behavioural data, the contribution of these few observations on psychotomimetics may be regarded as vanishingly small.

Comparison of tetrahydrocannabinol and synhexyl in man

These drugs differed from LSD in the following respects: sedation was prominent; euphoria was langer lasting; dreamlike sequences more pronounced; and physiological and biochemical effects were somewhat different, especially in the absence of sympathomimetic effects.

Delta‐9‐tetrahydrocannabinol and synhexl: Effects on human sleep patterns

The results of both types of experiments were consistent in demonstrating increments in Stage 4 sleep and decrements in REM sleep and their relation to the effects of other psychoactive compounds upon sleep patterns are discussed.

Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS).

Computerized quantitative analysis of the human scalp recorded electroencephalogram (EEG) proved to be useful for determination of psychoactivity and cerebral bioavailability of newly developed substances as for instance AX-A411-BS, a new benzodiazepine, which was found to be CNS-active and was classified as anxiolytic.

Delta-9-tetrahydrocannabinol and lysergic acid diethylamide: comparative changes in the supraoptic and paraventricular neurosecretory activities in rat hypothalamus.

Results indicated that chronic exposure of delta-9-THC lowered the functional activity of SON and PVN neurons while chronic LSD treatment stimulated the hypothalamo-neurohypophyseal neurosecretory system of rats.